Industrial Physicists Out-Earn Their Counterparts In Academia, Government

Physicists working for the government, however, have less reason to complain about being underpaid by comparison to the industrial scale: While young government physicists may start around $37,000 (versus $44,300 for industry) and may stay comparatively underpaid during the early stages of their careers, the salaries of older government physicists compare more favorably with those of industry physicists. Among the most experienced of them, in fact, median salaries in government come very close

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Physicists working for the government, however, have less reason to complain about being underpaid by comparison to the industrial scale: While young government physicists may start around $37,000 (versus $44,300 for industry) and may stay comparatively underpaid during the early stages of their careers, the salaries of older government physicists compare more favorably with those of industry physicists. Among the most experienced of them, in fact, median salaries in government come very close to those in industry: $67,700 versus $70,000.

The AlP based its analysis on salaries reported by more than 1,500 of its Ph.D. members in 1986, the most recent year for which its data are ready for release.

According to the survey, industry paid 19% more than govern- ment for the newest Ph.D.’s, 13% more for midcareer physicists (15 to 19 years after their degrees), and 3% more for the most experienced physicists (25 or more years after ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies